Relief Therapeutics Holding AG

Swiss biopharma Relief Therapeutics Holding SA develops patented treatments for rare dermatologic, metabolic, and pulmonary diseases—including SETOFILM/ONDISSOLVE for chemo‑induced nausea and RLF‑100 for ARDS, chronic lung conditions, and metabolic disorders.

Headquarters: Switzerland (CHE)

Relief Therapeutics Holding AG Logo
Company Profile
  • Employees: 28
  • HQ: Geneva
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
RLF Relief Therapeutics Holding AG
Cap: 0.0B
EQUITY EBS CHF CH0100191136 Active
📈
Home Login